In both HNSCC cohorts, the IWHMB of EGFR tyrosine kinase inhibitor resistance was high in late stage (TCGA HNSCC: p = 0.01, the mean difference > 0; chen’s cohort: p = 0.01, the mean difference > 0). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.